跳至主要内容
临床试验/PACTR201907742980888
PACTR201907742980888尚未招募未知

Evaluation of Efficacy and Safety of intramuscular glutathione as a systemic whitening agent: a double blinded randomized controlled clinical trial

Sohag University Hospital0 个研究点目标入组 30 人开始时间: 2019年4月22日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Healthy female aged between 18 to 50 years old fitzpatric skin type III and V.

排除标准

  • Personal or family history of skin cancer, especially melanoma.
  • Consumption of any preparations containing glutathione within 1month of enrollment.
  • Pigmentary disorders or any dermatoses, which may affect the measurement within the study areas.
  • Known hypersensitivity to glutathione.
  • Current pregnancy and lactation.
  • Current use of oral contraceptive pills or current receipt of hormone replacement therapy.
  • Regular participation in vigorous activities (e.g. sports) that includes exercise; occupational or leisure activities that involve daily sun exposure between 10.00 hours and 15.00 hours
  • A history of autoimmune disease, or immunodeficiency.
  • Major surgery, active or recent systemic infection within the previous four weeks.
  • History of liver diseases.

研究者

发起方
Sohag University Hospital

相似试验

Intramuscular glutathione as a systemic whitening... | 临床试验